Tissue Diagnostics Market

Roche (Switzerland), Danaher (US) are Leading Players in the Tissue Diagnostics Market

The global tissue diagnostics market is expected to reach USD 4.7 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 6.5%. The growth of this market is driven by the rising incidence of cancer, developing infrastructure for cancer diagnosis, increasing recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.

The prominent players operating in the global tissue diagnostic market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd (UK), and Dipath S.P.A. (Italy).

To know about the assumptions considered for the study download the pdf brochure

The players in this market are mainly focused on product launches/approvals, expansion, collaborations, partnerships, and acquisitions to develop and expand their market presence between 2017 and 2020.

Roche

Roche ranked first in the tissue diagnostic market in 2019. The company has a wide range of products for tissue diagnostics covering all major technologies of tissue diagnostics. Roche differentiates its products by branding them and launching new products in the field of tissue diagnostics. Product innovation is one of the major goals of the company, and the company launched innovative products over the last three years. For example, in 2019, the company introduced the VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy.

Danaher

Danaher ranked second in the tissue diagnostic market in 2019. The company has a broad product portfolio for tissue diagnostics. Danaher launched innovative products to enable rapid and accurate diagnosis from tissue samples. The company focuses on growing inorganically as it partnered with various companies over the last 3 years to strengthen its position in the tissue diagnostics market. For example, in 2017, the company entered into a partnership with the Kuwait Ministry of Health to enable efficient and rapid collaboration across hospitals and healthcare centers and create a nation-wide pathology network.

Related Reports:

Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories)-Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 2349
RI Published ON
5/13/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Tissue Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved